Company profile

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

Source: Cofisem - Last Update: 10 May 2019
Key Executives
Chief Executive Officer Jean Philippe Milon
Vice President Finance Marc Karako
Director Research & Development Fabrice Balavoine
Source: Cofisem - Last Update: 10 May 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 6 12
Consumed purchases 301 773 256 156
Payroll 2.403 2.456 1.823 1.600 1.302
Operating profit -13.598 -10.292 -6.216 -4.310 -2.418
Income tax -1.458 -1.150 -958 714 -335
Net income -11.990 -9.381 -5.241 -3.764 -2.207
Fiscal year end 12,18 12,17 12,16 12,15 12,14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 10 May 2019
Shareholder information
Free float 74,90 %
Institutional Funds 11,20 %
Managers 7,80 %
Tethys 6,10 %
Source: Cofisem - Last Update: 02 Apr 2019

Address

Quantum Genomics

33 Rue Marbeuf
FR-75008 Paris
France
Source: Cofisem - Last Update: 10 May 2019

Contact

Marc Karako
Phone number: +33 (0)1 85 34 77 75
Source: Cofisem - Last Update: 10 May 2019